120 related articles for article (PubMed ID: 6600484)
1. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
[TBL] [Abstract][Full Text] [Related]
4. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
6. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
7. Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens.
Natali PG; Viora M; Nicotra MR; Giacomini P; Bigotti A; Ferrone S
J Natl Cancer Inst; 1983 Sep; 71(3):439-47. PubMed ID: 6577218
[TBL] [Abstract][Full Text] [Related]
8. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
9. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
12. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
13. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
[TBL] [Abstract][Full Text] [Related]
14. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
[TBL] [Abstract][Full Text] [Related]
15. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
17. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen.
Giacomini P; Ng AK; Kantor RR; Natali PG; Ferrone S
Cancer Res; 1983 Aug; 43(8):3586-90. PubMed ID: 6344987
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
Hamby CV; Liao SK; Kanamaru T; Ferrone S
Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
